|On June 1, 2016 Canadian Cancer Trials Group's Division 5 training program will become mandatory for trials requiring a CTA application with Health Canada. The training program consists of a slide deck that summarizes the key aspects of Division 5 training and a short test consisting of a few questions.
There are two ways to confirm your training
- As of Wednesday June 1st, any investigator or CRA completing a patient randomization or registration will require completion of Division 5 training.
- As of Wednesday June 1st, any new study personnel added to a trial Participants List (PL) or changes made on a PL will require Division 5 training.
Important reminder letters containing this information were previously sent out to investigators and other external participants who have not yet completed the required Division 5 training. If you received one of these letters please ensure that you confirm your training as soon as possible. If you didn't receive a letter but will be participating in a trial with an investigational agent in the near future, you should take the training now to prevent being stopped from participating in the future.
- If you have already completed a similar educational course (including as part of an investigator or start up meeting please contact email@example.com
- Complete the Division 5 training program urgently. It is available in the toolbox on the Canadian Cancer Trials Group website at https://www.ctg.queensu.ca/public/ctg-toolbox Click on the link under training for "Division 5 - Canadian Food and Drug Regulations" to access the program.
Please contact firstname.lastname@example.org if you have any questions about the Division 5 training requirement due June 1, 2016.